Prevention of experimental autoimmune encephalomyelitis by MIP-1α and MCP-1 naked DNA vaccines

Journal of Autoimmunity

Volumn 13, Issue 1, 1999, Pages 21-29

  Youssef, Sawsan ^a   Wildbaum, Gizi ^a   Karin, Nathan ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

C C chemokines; Chemotaxis; CNS; DNA vaccination; Experimental autoimmune encephalomyelitis (EAE); MCP 1; MIP 1

Indexed keywords

BETA CHEMOKINE; DNA VACCINE; ENCEPHALITOGENIC PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CELLULAR IMMUNITY; CHEMOTAXIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOMODULATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SOUTHERN BLOTTING; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; VACCINATION;

EID: 0032794139     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0306     Document Type: Conference Paper

References (46)

1. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature. 385:1997;640-644.
2. Pan Y., Lloyd C., Zhou H., Dolich S., Deeds J., Gonzalo J.A., Vath J., Gosselin M., Ma J., Dussault B., Woolf E., Alperin G., Culpepper J., Gutierrez-Ramos J.C., Gearing D. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature. 387:1997;611-617.
3. Ben-Baruch A., Michiel D.F., Oppenheim J.J. Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem. 270:1995;11703-11706.
4. Ponath P.D., Qin S., Ringler D.J., Clark-Lewis I., Wang J., Kassam N., Smith H., Shi X., Gonzalo J.A., Newman W., Gutierrez-Ramos J.C., Mackay C.R. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:1996;604-612.
5. Carr M.W., Alon R., Springer T.A. The C-C chemokine MCP-1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes. Immunity. 4:1996;179-187.
6. Lloyd A.R., Oppenheim J.J., Kelvin D.J., Taub D.D. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J. Immunol. 156:1996;932-938.
7. Bacon K.B., Flores-Romo L., Aubry J.P., Wells T.N., Power C.A. Interleukin-8 and RANTES induce the adhesion of the human basophilic cell line KU-812 to human endothelial cell monolayers. Immunology. 82:1994;473-481.
8. Brown Z., Gerritsen M.E., Carley W.W., Strieter R.M., Kunkel S.L., Westwick J. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. Am. J. Path. 145:1994;913-921.
9. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood. 84:1994;2068-2101.
10. Jutila M.A. Role of changes in the vascular endothelium in chronic inflammation. Clin. Transplant. 8:1994;304-307.
11. Kim J.S., Gautam S.C., Chopp M., Zaloga C., Jones M.L., Ward P.A., Welch K.M. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J. Neuroimmunol. 56:1995;127-134.
12. Lukacs N.W., Strieter R.M., Elner V., Evanoff H.L., Burdick M.D., Kunkel S.L. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood. 86:1995;2767-2773.
13. Schall T.J., Bacon K., Camp R.D., Kaspari J.W., Goeddel D.V. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:1993;1821-1826.
14. Vaddi K., Newton R.C. Regulation of monocyte integrin expression by beta-family chemokines. J. Immunol. 153:1994;4721-4732.
15. Yu X., Graves D.T. Fibroblasts, mononuclear phagocytes, and endothelial cells express monocyte chemoattractant protein-1 (MCP-1) in inflamed human gingiva. J. Periodont. 66:1995;80-88.
16. Karpus W.J., Lukacs N.W., McRae B.L., Strieter R.M., Kunkel S.L., Miller S.D. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 55:1995;5003-5010.
17. Gong J.H., Ratkay L.G., Waterfield J.D., Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-1pr mouse model. J. Exp. Med. 186:1997;131-137.
18. Berman J.W., Guida M.P., Warren J., Amat J., Brosnan C.F. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 156:1996;3017-3023.
19. Karpus W.J., Kennedy K.J. MIP-1a and MCP-1 differentially regulate acute and relapsing experimental autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leuk. Biol. 62:1997;681-687.
20. Alvord E.C.J., Kies M.W., Suckling A.J. Experimental allergic encephalomylitis: a useful model for multiple sclerosis. Alvord E.C.J., Kies M.W., Suckling A.J., Allen R. Progress in clinical and biological research. Vol. 46. 1984.
21. MacFarlin D., MacFarland H. Multiple sclerosis. N. Engl. J. Med. 307:1983;1183-1188.
22. Karin N., Szafer F., Mitchell D., Gold D.P., Steinman L. Selective and nonselective stages in homing of T lymphocytes to the central nervous system during experimental allergic encephalomyelitis. J. Immunol. 150:1993;4116-4124.
23. Karin N., Mitchell J.D., Brocke S., Ling N., Steinman L. Reversal of experimental autoimmune encephalomyelitis by as soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of IFN-α and TNF-α production. J. Exp. Med. 180:1994;2227-2237.
24. Brocke S., Gijbels K., Allegretta M., Ferber I., Piercy C., Blankenstein T., Martin R., Utz U., Karin N., Mitchell D., Veromaa T, Waisman A., Gaur A., Conlon P., Ling N., Fairchild P.J., Wraith D.C., O'Garra A., Fathman G., Steinman L. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature. 379:1996;343-346.
25. Karin N., Binah O., Grabie N., Mitchel D.J., Felzen B., Solomon M.D., Conlon P., Gaur A., Ling N., Steinman L. Short peptide based tolerogens without antigenic activity reverse autoimmunity. J. Immunol. 160:1998;5188-5149.
26. Yednock T.A., Cannon C., Fritz L.C., Sanchez M.F., Steinman L., Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4 β1 integrin. Nature. 356:1992;63-66.
27. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., Friedman A., Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein [see comments]. Science. 259:1993;1745-1749.
28. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M.L., Chattergoon M., Frost P., Javadian A., Williams W.V., Refaeli Y., Ciccarelli R.B., McCallus D., Coney L., Weiner D.B. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [see comments]. Nat. Med. 3:1997;526-532.
29. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:1997;816-826.
30. Kim J.J., Bagarazzi M.L., Trivedi N., Hu Y., Kazahaya K., Wilson D.M., Ciccarelli R., Chattergoon M.A., Dang K., Mahalingam S., Chalian A.A., Agadjanyan M.G., Boyer J.D., Wang B., Weiner D.B. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat. Biotechnol. 15:1997;641-646.
31. Raz E., Watanabe A., Baird S.M., Eisenberg R.A., Parr T.B., Lotz M., Kipps T.J., Carson D.A. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Nat. Acad. Sci. USA. 90:1993;4523-4527.
32. Raz E., Tighe H., Sato Y., Corr M., Dudler J.A., Roman M., Swain S.L., Spiegelberg H.L., Carson D.A. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA. 93:1996;5141-5145.
33. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatoey DNA sequinces necessery for effective intradermal gene immunization. Science. 273:1996;352-357.
34. Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory D., Lowrie D.B. Vaccination against tuberculosis by DNA injection. Nat. Med. 2:1996;888-892.
35. Waisman A., Ruiz P.J., Hirschberg D.L., Gelman A., Oksenberg J.R., Brocke S., Mor F., Cohen I.R., Steinman L. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2:1996;899-905.
36. Lanir N., Ciano P.S., Van de Water L., McDonagh J., Dvorak A.M., Dvorak H.F. Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration. J. Immunol. 140:1988;2340-2349.
37. Luo Y., Laning J., Devi S., Mak J., Schall T.J., Dorf M.E. Biologic activities of the murine beta-chemokine TCA3. J. Immunol. 153:1994;4616-4624.
38. Ulmer, J.B. Sadoff, J.C. Liu, M.A. 1996, DNA vaccines. Current opinion in immunology, 8, 531, 536.
39. Fu T.M., Ulmer J.B., Caulfield M.J., Deck R.R., Friedman A., Wang S., Liu X., Donnelly J.J., Liu M.A. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol. Med. 3:1997;362-371.
40. Steinman L. Escape from 'horror autotoxicus': pathogenesis and treatment of autoimmune disease. Cell. 80:1995;7-10.
41. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:1994;991-1045.
42. Janeway C.A. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today. 13:1992;1-16.
43. Cyster J.G., Hartley S.B., Goodnow C.C. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire [see comments]. Nature. 371:1994;389-395.
44. Riethmuller G., Rieber E.P., Kiefersauer S., Prinz J., van der Lubbe P., Meiser B., Breedveld F., Eisenburg J., Kruger K., Deusch K., Sanders M., Reiter C. From antilymphocyte serum to therapeutic monoclonal antibodies: first experiences with a chimeric CD4 antibody in the treatment of autoimmune disease. Immunol. Rev. 129:1992;81-104.
45. Green L.L., Hardy M.C., Maynard-Currie C.E., Tsuda H., Louie D.M., Mendez M.J., Abderrahim H., Noguchi M., Smith D.H., Zeng Y., David N.E., Sasai H., Garza D., Brenner D.G., Hales J.F., McGuinness R.P., Capon D.J., Klapholz S., Jakobovits A. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat. Gene. 7:1994;13-21.
46. Glabinski A.R., Tani M., Strieter R.M., Tuohy V.K., Ransohoff R.M. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150:1997;617-630.